Alvotech
NASDAQ:ALVO 4:00:00 PM EDT
| Market Cap (Intraday) | 2.45B |
| Current PE | 38.68 |
| Forward PE | 27.07 |
| 2yr Forward PE | 10.68 |
| 10-Day MA | $8.11 |
| 50-Day MA | $8.57 |
| 200-Day MA | $10.33 |
Alvotech Stock, NASDAQ:ALVO
9, rue de Bitbourg, 28th floor, Luxembourg, Luxembourg 1273
Luxembourg
Phone: +352.422.4500
Number of Employees: 1026
Description
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by R�³bert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.